Hemoglobinopathies Market Current Status, In-depth Analysis and Forecast Outlook 2027

The Global Hemoglobinopathies Market size was valued at USD 7.1 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 10% from 2021 to 2027.

Hemoglobinopathy is a genetic disorder that causes structural abnormalities in the hemoglobin molecule, particularly defective globin chains. Hemoglobinopathy is a hereditary single-gene disease, with sickle cell disease being the most common type. The prevalence of hemoglobinopathy is high in Africa, Southeast Asia, and the Mediterranean basin. If left untreated, serious cases of hemoglobinopathy lead to anemia, organ dysfunction, or death. Gel electrophoresis and complete blood count are used as diagnostic tests to determine the presence of hemoglobinopathy. There is no permanent cure for this disease. This has increased the demand for new product innovations in the pharmaceutical sector.

 

(Get 15% Discount on Buying this Report)

Get Sample at: https://www.orionmarketreports.com/request-sample/?id=56819    

                                                 

 Market Segments

 

Key Players

 

  • Alnylam Pharmaceuticals
  • Gamida Cell
  • Biogen Idec
  • AcceleronPharma
  • Sangamo BioSciences
  • Anthera Pharmaceuticals
  • Global Blood Therapeutics
  • Genetix Pharmaceuticals
  • Mast Therapeutics
  • Prolong Pharmaceuticals
  • Emmaus Medical
  • Calgene Corporation
  • Invenux
  • Optinova Ab
  • HemaQuest Pharmaceuticals.

 

By Test Type

 

  • Red blood cell (RBC) count test
  • Genetic testing, hemoglobin by high performance liquid chromatography (HPLC) test
  • Hemoglobin isoelectric (Hb IEF) focusing
  • Hemoglobin electrophoresis (Hb ELP) test
  • Hemoglobin solubility test.

 

By End User

 

  • Hospitals
  • Diagnostic Laboratories
  • Clinics

 

By Indication Type

 

  • Sickle Cell Disease
  • Alpha Thalassemia
  • Beta Thalassemia

 

By Region

 

Europe

 

  • France
  • UK

 

South America

 

  • Argentina
  • Brazil

 

Asia Pacific

 

  • Japan
  • India

 

A full report  is available at : https://www.orionmarketreports.com/hemoglobinopathies-market/56819/ 


Scope of the Heart

The research study analyzes the global Hemoglobinopathies Market industry from 360-degree analysis of the Market thoroughly delivering insights into the Market for better business decisions, considering multiple aspects some of which are listed below as:

 

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

For more customized data, request for report customization @   https://www.orionmarketreports.com/inquiry-before-buying/?id=56819   

 About it

Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative Market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth Market insights and most reliable future Market trends. Our reports address all the major aspects of the Markets providing insights and Market outlook to global clients.

Media Contact:

Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionMarketreports.com
Contact no: +91 780-304-0404

 

(This release has been published on Global Market Post.
Global Market Post is not responsible for any content included in this release.)

Leave a Reply

Your email address will not be published. Required fields are marked *